Identifying how to strategically leverage AI to create scalable efficiencies and growth

Leverage our 20 years of expertise in biopharma strategic AI/ML/NLP  to ensure success.

We do not apply AI/Futuretech without starting with a strategic analysis of your company and business units needs in order to create solutions that move the needle for strong business impact.

AI/FutureTech Brings New Opportunities for Efficiency and Growth for Pharma but only if planned strategically

With all the challenges facing biopharma today, including the looming patent cliff and associated job cuts, slow processes to get to market, supply chain challenges, time-intensive human-powered processes (especially in R&D, medical affairs, and market access), and difficulty accessing HCPs, pharma turn to tech and AI to help ‘digitally transform’ the organization. 

However, most of these efforts tend to be tech-led rather than strategy-led, leading to expensive mistakes and an inability to scale effectively and minimal measurable impact on the company’s future – and a less-than-impressed Board.

McKinsey reports that 85% of AI projects do not deliver the return anticipated. Given what we see when we go into pharma companies, we are not surprised. Very few AI and FutureTech workstreams are strategy-led which they must be in order to deliver the anticipated results.

At Eularis we always start with a strategy to ensure our clients achieve real-world business results including efficiency, speed, and revenue growth from all their AI and FutureTech initiatives. 

Our 4 core services

Click on any of our 4 offerings below to understand more about our process and what do to achieve the results that we do.

AI Strategic Blueprint

Identifying the optimal path for maximum impact with AI to solve real-world challenges in biopharma.

AI strategic blueprints designed to unearth efficiency and growth

Click here to find out more

AI Strategy, Advisory and Competency Development Programs

Strategy and Advisory

An ongoing program ensuring you gain results from AI. Specifically designed program for Biopharma and Agencies.
Click here to find out more

AI Implementation

End-to-end solutions-focused AI implementation

AI Implementation designed to be lean and effective

Click here to find out more

Training in AI for Pharma

Go from novice to expert in 2 days

AI Training

A fully-focused results-producing, program on AI strategy specifically curated and designed for Pharma Professionals
Click here to find out more

Engage Dr Bates for your keynote

Insightful, engaging keynotes about the use of AI and FutureTech in Pharma, Digital Health,

Experience an award winning speaker

An engaging and inspiring keynote speaker known for her uniquely 'on point' presentations with hundreds of keynotes completed for top pharma companies including Bayer, CSL Behring, Novartis, Bristol Myers Squibb, Merck, EMD Serono, Merck Serono, and many more.
Learn more

Strategic AI training for Pharma

Upskill your team with custom training from Eularis created to meet your unique needs.

World class training

Eularis offer a wide range of training courses around pharma uses of AI. These encompass both executive/business teams training on understanding and how to plan strategic use of AI for their company, as well as training for non-technical commercial fold on what AI is, and planning the use of AI in areas such as sales and marketing and market access.
Learn more

ACCELERATE LAB

Ensuring the key foundational elements required for success in your AI/FutureTech projects are in place.

PAINLESS IMPLEMENTATION

1007 projects foundational elements implemented / Sped up time to implementation / X5 speed to value
Learn More

TRANSFORMATION ENGINE

Assess emerging risks, identify drivers and sources of sustainable competitive advantage, and how to leverage these for sustainable growth.

SUSTAINABLE GROWTH

World firsts in pharma AI strategy / sales decline transformed into double-digit growth/ 79% of our launch brands market leaders within 1 year
Learn More

Future-Proof Pharma Labs

We don’t leave pharma success to chance. Our Virtual Future-Proofing Pharma Labs are 4, 6 or 12-month engagement and acceleration mechanisms that turn pharma challenges into a reliable, scalable future-proofed pharma. Our goal is to ensure that your company is future-proofed with data, AI and tech for your biggest challenges across the value chain.

AI-Strategy and AI End-to-End Build

For go-to-market planning and brand growth fuelled by AI, we help you plan your strategic approach. With extensive experience in AI in Pharma, Eularis provide support in the all stages of strategic planning for use of AI in, or for, your company. By doing thorough planning prior to beginning your project, you will be able to plan for success.

AI Training for Commercial Teams​

Eularis offer a wide range of training courses for AI in pharma designed to give you the skills and strategic edge needed for your teams to get results faster. Join an existing on-demand training or get one designed for your specific needs. Learn faster from others who have already done it!

AI Speaking Engagements

Dr Andree Bates regularly speaks at Pharmaceutical industry conferences, internal pharmaceutical company events, as well as industry organizations, and University MBA classes since 1999. She has delivered well over 200 presentations and is always a well-received speaker.

“Thank you very much. Very comprehensive.”

Global Digital IT Information Architect

Roche

"I worked closely with Andree and the team at Eularis on a 4-month project. Andree has the unique ability to quickly get up to speed on an organization's strategic focus and distill complex information into a simplified format that allows a leadership team to provide appropriate input and guidance. I always looked forward to our weekly calls and learned something new in every single one. She is well organized, asks insightful questions, and has a knowledge of AI and the pharmaceutical industry that is unparalleled. The output of our project was high value for our entire organization, and I look forward to working with Andree again."

Nicole Winders, Team Lead, Omnichannel Excellence

Boehringer Ingelheim

“During my 30 years of career in senior executive roles in the life sciences industry, I have met few professionals as gifted as Andrée Bates. Andrée demonstrated her abilities as a skilled professional in the services to the life science industry before revealing her entrepreneurial spirit and edge through the success of Eularis. In the various instances in which we have been collaborating, Andrée displayed an in-depth understanding of the matter and of the broader context of the challenges faced by the industry. She is truly capable of seeing the broad strategic picture. Her broad professional knowledge and her proven ability to work across cultures are genuine assets for global advisory roles and board director positions. “

Dr Pierre Morgon, Chief Executive Officer, Chairman of the Board

MRGN ADVISORS, Chairman of the Board of Health Technology Holding plus many other board roles, ex Vice President Global Marketing Strategy, Sanofi-Pasteur

"The feedback I have received from our students has been 'Amazing'. I know you have a very busy schedule but do keep in touch with us. Your area of work is of great interest to our center."

Professor Falguni Sen, Director

Global Healthcare Innovation Center (GHIM) , Fordham University

“Andrée is a very dynamic, cheerful person with tremendous insight into the mechanics of the pharma business, gained over many years of professional life in this industry. Her prime expertise is, of course, in the commercial side of the business but she has an intelligent read of the bigger picture, too. She is a great person to work with, goal oriented and team spirited. She can take tough decisions and quickly sorts the true from the false. She radiates positive energy. In her role as a consultant, she has proven that she can be very efficient playing the role of an enabler, contributing substantially to the success of those in charge: a perfect fit for a BoD role and position. Her entrepreneurial drive and capabilities are beyond questioning: Look at EULARIS!”

Dr. Stefan Manth, Chief Executive Officer

Mologen AG, ex Head of Personalized Medicine Strategy for Roche

" The CEO meeting went very well yesterday and your transformation strategy definitely contributed to that. Thank you. The entire board were impressed and I am sure we will get the green light to proceed very soon. I will be in touch."

CTO

Top 20 Pharma

” I have known Andree for many years and she has always been, and remains ahead of the AI curve in Pharma/Biotech in seeing where things are going, being an early adopter/innovator in this space. She is consistently approachable, professional, and highly knowledgeable about pharma uses of AI. Great capability to integrate an understanding of the pharma space with a strategic AI approach that delivers real-world results that stand out from the crowd that makes Andree a great leader in AI and future-proofing strategies in pharma. Highly customer-focused and always does her best for her clients which makes me have no doubt Andree would be a real asset to any company requiring expertise in this area and would not hesitate in recommending her investments.”

Paul Runeckles. Senior Leader Commercial Excellence/SFE/Capabilities/Omnichannel

Ferring Pharmaceuticals

“Thank you very much for your high-octane event. Not only did I learn what I can do next, I thoroughly enjoyed the day.”

Associate Director European Marketing

Sanofi

” I have known Dr. Andree Bates for many years as she frequently visits Japan where I work. Dr. Bates has been among the very first to explore and promote data analytics services using advanced technologies to support pharmaceutical companies efforts in forecasting, epidemiology, patient model and treatment algorithms. In many areas, her insight and experience have been very valuable references to my own efforts to promote innovative approaches in GSK Japan then, and now inside CMIC Holdings. I therefore endorse Dr. Bates.”

Philippe Auvaro, Managing Director

CMIC Holdings ,Japan

" Thank you for partnering with me on this future-proofing strategy. The Board found it compelling, especially that while future-proofing we are able to deliver measurable milestones and results that reshape the business. Thank you again. "

Global Head of Planning, Strategy and Operations

Top 20 Pharma

“I wanted to deeply thank you for an amazing presentation you gave to our employees. It was eye-opening and many of my colleagues are talking about how well and exciting your presentation was. There is a lot of buzz on your topics.”

Director of Business IT Solutions

Bayer

Pharma all want company growth and profit. This is typically accomplished via two routes: one is mergers and acquisitions, and the other is… Dr Andree Bates.

Dr Paul Tunnah

Founder Pharmaphorum, MD of Healthware Group

The analysis provided turned out to be highly accurate and very effective for increasing prescriptions in the order predicted.

Group Product Manager

Merck

"Thank you for your wonderful talk and presentation. It was great to see you again and share your extensive knowledge with our team. Your presentation inspired interest and have everyone a much better understanding of AI capability and application. All the comments received afterwards were incredibly positive. I think everyone was genuinely impressed with how ‘on point’ it was an seeing actual healthcare examples was fantastic.:"

Howie Jones, Studio Director

McCann Health

Strengthen your competitive edge & achieve stronger growth

Many pharma and healthcare executives are aware that AI will disrupt their business, but they are in sales and marketing, so they don’t think they have a role in it. In fact, they worry that their role will eventually disappear unless they can understand and embrace the changes. And this is true. Many roles will go.  By not avoiding, but embracing, the change, marketers can have a strategic advantage and ride the wave of innovation and supercharge their careers , or they an drown.

In order to succeed, AI initiatives must be strategically planned with business outcomes in mind and executed effectively.

Increase the success of your AI initiatives by ensuring the appropriate use cases and business cases are properly  planned for strong business return by someone who understands the business itself.

Given the time and cost that can be involved in doing AI projects, as well as the enormous transformative gains that can be created, it is critical that your company approach AI projects the optimal way.

By working with Eularis you will ensure that you are planning the optimal AI project to meet your strategic objectives, and by thorough planning ensure that your projects start – and stay – on track to deliver valuable, measurable outcomes for the business.

Here are the most common ways that Eularis helps our clients using our AI consultancy service

  • Work with client teams to discover where AI might be most appropriately used to support your brand or company to meet measurable outcomes to solve your business challenges or objectives.
  • Identify a business case that supports your big data universe to ensure that the maximum value is gained from your data.
  • Identify which types of data and AI would be most suitable to provide the right analysis for your project/s.
  • With a clear strategy and definition of business issues we can create an AI strategy roadmap for you to define the optimal potential projects and how to proceed.
  • Help you choose the right AI vendor for your project.
  • We can support your decision process on how to scale these project.
  • Inform your C-suite or other leadership groups about the potential of AI in your company.
  • Due diligence on Healthcare or pharma AI (including machine learning) technologies prior to acquisition to provide a comprehensive and unbiased assessment.
  • Figure out where the technology is heading in your space and what will differentiate the winners and the losers and how to be in the former group.

Need some help?

For assistance in deciding how we can best support your needs, contact Eularis for a confidential discussion today.

Seize the opportunities challenge brings

Here are the most common ways that Eularis helps our clients.

  • Create a strategic AI blueprint across any business units in the value chain (e.g. R&D, Clinical, Supply Chain, Medical Affairs, Market Access, Regulatory, PV, Sales and marketing. These are usually presented to the Board as part of their corporate strategy.
  • Identify the optimal AI approach to solve pharma clients’ specific challenges with strategic AI and FutureTech – anywhere in the value chain.
  • Identify a business case that supports your big data universe to ensure that the maximum value is gained from your data.
  • Identify which types of data you need and where to source it ethically and compliantly.
  • Assist clients to get their internal legal and compliance teams’ approval for AI projects.
  • Planning the tech SOW.
  • Future-proof our pharma client processes for sustainable growth across the value chain.
  • Help you choose the right AI solution or vendor for your project.
  • Work with client teams to discover where AI might be most appropriately used to support sustainable reliable growth.
  • Guidance on how to scale your pilot projects.
  • Guiding your C-suite or other leadership groups about how to leverage AI/ FutureTech to achieve their specific corporate objectives.
  • Creating a future-proofed company.
  • Due diligence on specific AI (including machine learning) technologies or companies prior to acquisition to provide a comprehensive and unbiased assessment.
  • Assessing where the technology is heading in your space and what will differentiate the winners and the losers and how to utilise this knowledge for sustainable competitive advantage.
 

Discover how our strategic AI Blueprint guide pharma leaders to solve their biggest challenges using AI and FutureTech.

Let us help you fast track your results

Hi, I’m Andrée. I have worked in Pharmaceuticals for 29 years, digital pharma for 27 years, and Artificial Intelligence in healthcare for almost 2 decades.

During that time I have had the privilege to work on over a thousand pharma AI strategies in healthcare. I have lived through the ups and downs of all those projects, and I have made mistakes in the early days.  But, from that I learned what you should do, and what you should not do, to achieve a successful result. Let me guide you to success.

'For over 19 years, we have strategically planned and accelerated over a thousand AI projects for pharma. Our understanding of the pharmaceutical value chain, external market drivers and adjacent industries means that solving the most complex pharma challenges is something we excel at. Today, my team and I, help pharmaceutical CEOs and boards and Team leaders collaborate more effectively by unearthing unique innovative approaches to solve challenges and create growth opportunities no matter what the environment.'

No matter what your challenge, with over 1,000 healthcare AI strategies completed, we have seen most things you can think of. Contact us to discuss your specific needs confidentially.

Discover how AI can deliver growth for you.

Learn more about planning AI to solve challenges with our training program!